SA could ameliorate L-NAME induced preeclampsia, which also improved the proliferation and migration rate of L-NAME-stimulated HTR-8/SVneo, and we demonstrated that SA can ameliorate preeclampsia by activating the PI3K/AKT/eNOS pathway, as confirmed through quantitative proteomics and molecular biology techniques. The gene discussed is AKT1; the disease is preeclampsia.